The Wolverine Blend puts BPC-157 and TB-500, two of the most popular healing peptides, into a single pre-mixed vial. BPC-157 drives local tissue repair and angiogenesis through VEGF, nitric oxide, and growth-hormone-receptor pathways, while TB-500 works systemically through actin modulation. Reports describe faster recovery than either compound alone, though the healing evidence is still mostly animal.
- BPC-157 activates VEGF, nitric oxide, and growth-hormone-receptor pathways for local repair; TB-500 adds systemic actin modulation.PubMed (BPC-157 + TB-500)
- The pairing is reported to recover tissue faster than either peptide alone, with structural repair over 4-12 weeks and a systemic anti-inflammatory effect layered on localized healing.peptidedosages
- In animal studies BPC-157 protected against NSAID-driven gut and liver damage, so the old belief that NSAIDs cancel the blend out is a myth, though the guide still lists NSAIDs under Avoid during a repair cycle because they slow healing on their own.The Complete Peptide Guide
- In July 2026 the FDA's PCAC voted 8-6 to recommend both BPC-157 and TB-500 for the 503A compounding bulks list, an advisory, non-binding signal that follows BPC-157's 2023 Category 2 placement.The Complete Peptide Guide
- Honest limit: there are no published human RCTs for the combination, so the repair data is animal and observational.The Complete Peptide Guide